Sandra Levy
ARTICLES BY THIS AUTHOR
- 11/20/2019
60 Degrees Pharmaceuticals launching Arakoda
Arakoda, the first antimalarial product approved by the Food and Drug Administration for the prevention of malaria, is being made available at select pharmacies and wholesalers. - 11/20/2019
FDA approves new indication of AstraZeneca's Calquence
As part of an international collaboration, the FDA has approved AstraZeneca's new treatment option for patients with chronic lymphocytic leukemia. - 11/19/2019
Novartis gets FDA nod for Adakveo
Novartis’ Adakveo is the first targeted therapy to treat patients with a painful complication of sickle cell disease. - 11/19/2019
Alnylam gets FDA green light for Givlaari
Alnylam’s Givlaari has been approved by the FDA to treat a genetic disorder the causes buildup of toxic porphyrin molecules, which are formed during the production of heme. - 11/19/2019
SingleCare prescription savings services debuts Drug Basket
SingleCare's Drug Basket feature helps consumers get the lowest prices for prescription drugs at nearby pharmacies. - 11/18/2019
Lupin launches generic potassium chloride oral solution
Potassium chloride for oral solution, 20 mEq, had a market value of roughly $90 million, according to IQVIA data from September 2019. - 11/18/2019
NACDS Foundation honors Project Lifeline leaders for opioid abuse prevention work
The NACDS Foundation will present its Excellence in Patient Care Award to Janice Pringle and Judy Rosser. - 11/18/2019
Propeller Health adds retail pharmacy chains to its app
Customers can access pharmacy services from Walgreens, CVS, Walmart, Kroger and Rite-Aid via Propeller Health's app. - 11/18/2019
Zydus Cadila gets tentative FDA nod for generic Otezla
Zydus Cadila's generic Otezla provides a treatment for psoriatic arthritis, and mouth sores for people with Behcet's disease. - 11/17/2019
FDA approves Pfizer's Humira biosimilar, offers update on progress biosimilar approvals
Pfizer plans to launch Humira biosimilar in 2023.
